CJC-1295 + Ipamorelin Blend 10MG (no DAC)
A blended research vial pairing a GHRH analog (CJC-1295 without DAC) with a selective growth hormone releasing peptide (Ipamorelin) for investigation of pulsatile GH release, dual GHRH/GHRP signaling, and endocrine pathway research. For CJC-1295 (no DAC) + Ipamorelin Blend, each vial is labeled 10MG, CAS Blend (863288-34-0 · 170851-70-4).
Published laboratory work with CJC-1295 (no DAC) + Ipamorelin Blend has examined pulsatile growth hormone axis, dual GHRH/GHRP signaling studies, endocrine pathway research models. Each lot is manufactured under sterile conditions, lyophilized in single-use research vials, and labeled with its production lot for traceability.
Supplied for in-vitro laboratory research use only. Not for human or veterinary consumption, administration, diagnostic or therapeutic use.
Combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) commonly researched together for pulsatile growth hormone axis studies.
Background reading on this compound in the ENOS Lab Notes: CJC-1295 and Ipamorelin: Receptor Research Review.
Background reading: the CJC-1295 compound reference, how to read a certificate of analysis, why purity and identity are separate tests and storage and handling guidance.
Comparing GHRH analogs? See Tesamorelin 10MG.
- Ships from Arizona
- Free shipping through Nov 14
- Zelle, Venmo, Cash App, USDT
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Compound identity
Listed on the storefront as CJC-1295 + IPA Blend. The compound information for this research vial is below.
- Compound name
- CJC-1295 (no DAC) + Ipamorelin Blend
- Also known as
- CJC-1295 no DAC, Modified GRF (1-29), Mod GRF 1-29 + Ipamorelin, CJC IPA blend
- Molecular formula
- Blend: see individual components (CJC-1295 (no DAC), Ipamorelin)
- Molecular weight
- Blend: see individual components (CJC-1295 (no DAC), Ipamorelin)
- CAS number
- Blend (863288-34-0 · 170851-70-4)
- Vial size
- 10MG
Product Information
Research DatasheetProduct Overview
A blended research vial pairing a GHRH analog (CJC-1295 without DAC) with a selective growth hormone releasing peptide (Ipamorelin) for investigation of pulsatile GH release, dual GHRH/GHRP signaling, and endocrine pathway research. Lyophilized under sterile conditions. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Pulsatile growth hormone axis research
- ◆Dual GHRH/GHRP signaling studies
- ◆Endocrine pathway research models
- ◆Comparative secretagogue pharmacology
- ◆Peptide blend stability research
Quality Standards
Lab documentation: available on request, info@enosusa.com
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) commonly researched together for pulsatile growth hormone axis studies. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate.
- ◆Dual pathway blend
- ◆Growth axis research
- ◆GHRH plus GHRP pairing
You may also like
HYROX Fat Burner Stack · Retatrutide + CJC-1295 + IPA + GHK-Cu
Incretin receptor, GHRH/ghrelin receptor and copper peptide research bundle.
HGH · 10 × 10IU Kit
Recombinant human growth hormone (rhGH) research kit, 10 vials of 10IU.
Tesamorelin · 10MG
GHRH analog research peptide studied in pulsatile growth hormone release models.